Dx Deals: Labcorp Continues Dealmaking with Incyte Asset Acquisition in Washington State
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
How automation, artificial intelligence, and other emerging technologies are elevating the efficiency and output of labs’ revenue cycles
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Experts Nathan Buchbinder and Julianna Ianni discuss digital pathology and AI trends in 2024—and what the next year may hold
How labs can better use their valuable data and highlight that data’s benefits to the health systems they serve
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
With strikes increasing across industries, what happens if workers involved in the ancillary services labs depend on go on strike?
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays